Melancholic and reactive depression: A reappraisal of old categories

BMC Psychiatry

Volumn 13, Issue , 2013, Pages

  Mizushima, Jin ^a   Sakurai, Hitoshi ^a   Mizuno, Yuya ^a   Shinfuku, Masaki ^a   Tani, Hideaki ^a   Yoshida, Kadunari ^a   Ozawa, Chisa ^a   Serizawa, Asako ^a   Kodashiro, Natsuko ^a   Koide, Shinya ^a   Minamisawa, Atsumi ^a   Mutsumoto, Eisaku ^a   Nagai, Nobuhiro ^a   Noda, Sachiko ^a   Tachino, Genichiro ^a   Takahashi, Tatsuichiro ^a   Takeuchi, Hiroyoshi ^a   Kikuchi, Toshiaki ^a,b   Uchida, Hiroyuki ^a   Watanabe, Koichiro ^a   Kocha, Hiroki ^a   Mimura, Masaru ^a   more..

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Zama Mental Clinic   (Japan)

Author keywords

Antidepressant; Diagnosis; Melancholic depression; Newcastle scale; Reactive depression

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; HYPNOTIC AGENT;

ADULT; ARTICLE; CLINICAL PRACTICE; DISEASE SEVERITY; DSM-IV-TR; ELECTROCONVULSIVE THERAPY; FEMALE; HEALTH SURVEY; HUMAN; JAPAN; LIKERT SCALE; MAJOR DEPRESSION; MALE; MELANCHOLIA; NORMAL HUMAN; PATIENT CARE; PSYCHIATRIST; PSYCHOTHERAPY; QUESTIONNAIRE; REACTIVE DEPRESSION; SCORING SYSTEM;

ADJUSTMENT DISORDERS; ADULT; ANTIDEPRESSIVE AGENTS; ATTITUDE OF HEALTH PERSONNEL; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; JAPAN; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84887562553     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-13-311     Document Type: Article

References (25)

1. Parker G. Classifying depression: should paradigms lost be regained?. Am J Psychiatry 2000, 157(8):1195-1203. 10.1176/appi.ajp.157.8.1195, 10910777.
2. Fink M, Bolwig TG, Parker G, Shorter E. Melancholia: restoration in psychiatric classification recommended. Acta Psychiatr Scand 2007, 115(2):89-92. 10.1111/j.1600-0447.2006.00943.x, 3712974, 17244171.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders - DSM-IV-TR 2000, Washington DC: American Psychiatric Association, 4, Text Revision, American Psychiatric Association.
4. World Health Organization The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines 1992, Geneva: World Health Organization, World Health Organization.
5. Bauer M, Bschor T, Pfenning A, Whybrow PC, Angst J, Versiani M, Möller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry 2007, 8(2):67-104. 10.1080/15622970701227829, 17455102.
6. Pilling S, Anderson I, Goldberg D, Meader N, Taylor C. Depression in adults, including those with a chronic physical health problem: summary of NICE guidance. BMJ 2009, 339:b4108. 10.1136/bmj.b4108, 3230232, 19861376.
7. Ghaemi SN, Vohringer PA. The heterogeneity of depression: an old debate renewed. Acta Psychiatr Scand 2011, 124:497. 10.1111/j.1600-0447.2011.01746.x, 22077848.
8. Parker G, Fink M, Shorter E, Taylor MA, Akiskal H. Issues for DSM-5: whither melancholia? The case for its classification as a distinct mood disorder. Am J Psychiatry 2010, 167(7):745-747. 10.1176/appi.ajp.2010.09101525, 3733615, 20595426.
9. Brown WA. Treatment response in melancholia. Acta Psychiatr Scand Suppl 2007, 433:125-129.
10. Schneider K. Die Schichtung des emotionalen Lebens und der Aufbau der Depressionszustande. Z Gesamte Neurol Psychiatr 1920, 59:281-286.
11. Carney MW, Roth M, Garside RF. The diagnosis of depressive syndromes and the prediction of E.C.T. response. Br J Psychiatry 1965, 111:659-674. 10.1192/bjp.111.477.659, 14337413.
12. Roth M, Gurney C, Mountjoy CQ. The Newcastle rating scales. Acta Psychiatr Scand Suppl 1983, 310:42-54.
13. Gurney C. Diagnostic scales for affective disorders. In Proceedings of the fifth world conference of Psychiatry 1971, 330. Mexico City.
14. Higuchi T. Major depressive disorder treatment guidelines in Japan. J Clin Psychiatry 2010, 71(Suppl. E1):e05.
15. Davidson JRT. Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry 2010, 71(Suppl E1):e04.
16. Judd LL, Schettler PJ, Akiskal HS. The prevalence, clinical relevance, and public health significance of subthreshold depressions. Psychiatr Clin North Am 2002, 25(4):685-698. 10.1016/S0193-953X(02)00026-6, 12462855.
17. Targum SD, Pollack MH, Fava M. Redefining affective disorders: relevance for drug development. CNS Neurosci Ther 2008, 14(1):2-9. 10.1111/j.1755-5949.2008.00038.x, 18482094.
18. American Psychiatric Association Practice Guideline for the Treatment of Patients With Major Depressive Disorder 2010, Third, http://psychiatryonline.org/content.aspx?bookid=28§ionid=1667485, American Psychiatric Association.
19. Shorter E. The doctrine of the two depressions in historical perspective. Acta Psychiatr Scand Suppl 2007, 433:5-13. 3712975, 17280565.
20. Imlah NW. An evaluation of alprazolam in the treatment of reactive or neurotic (secondary) depression. Br J Psychiatry 1985, 146:515-519. 10.1192/bjp.146.5.515, 2861873.
21. Monane M, Avorn J. Medication and falls. Causation, correlation, and prevention. Clin Geriatr Med 1996, 12(4):847-858.
22. Vermeeren A, Coenen AM. Effects of the use of hypnotics on cognition. Prog Brain Res 2011, 190:89-103.
23. Gallacher J, Elwood P, Pickering J, Bayer A, Fish M, Ben-Shlomo Y. Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS). J Epidemiol Community Health 2011, Oct, 66(10):869-873.
24. Lader MH. Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?. Eu Neuropsychopharmacol 1999, 9(Suppl 6):S399-405.
25. O'brien CP. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry 2005, 66(Suppl 2):28-33.